Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,299 papers from all fields of science
Search
Sign In
Create Free Account
Resectable Small Intestinal Carcinoma
Known as:
Resectable Small Bowel Carcinoma
, Small Intestine Carcinoma, Resectable
, Resectable Carcinoma of the Small Intestine
Expand
Carcinoma of the small intestine amendable to resection.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Abdominal Pain
Crohn Disease
Epithelial Cells
Epithelium
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancer.
Andrew J Benjamin
,
M. Buschmann
,
+4 authors
W. Dale
Journal of Geriatric Oncology
2018
Corpus ID: 3848013
Review
2016
Review
2016
Peri-operative modified FOLFIRINOX (mFOLFIRINOX) in resectable pancreatic cancer (PDAC): A pilot study.
R. Marsh
,
M. Baker
,
+6 authors
H. Kindler
2016
Corpus ID: 78568183
312 Background: Surgical resection plus adjuvant gemcitabine or 5-FU is standard therapy for resectable PDAC. Infusional 5-FU…
Expand
2015
2015
Adoptive cell transfer after chemotherapy enhances survival in patients with resectable HNSCC.
P. Jiang
,
Yan Zhang
,
Steve J Archibald
,
Hua Wang
International Immunopharmacology
2015
Corpus ID: 21194948
Review
2014
Review
2014
Place of hepatic intra-arterial chemotherapy in the treatment of colorectal liver metastases.
M. Allard
,
D. Malka
Journal of visceral surgery
2014
Corpus ID: 3071024
2014
2014
Influence of Pathologic Complete Response to Induction Chemotherapy onLong-Term Survival of Patients Advanced Squamous Cell Carcinoma of the OralCavity Tongue
Xin-rui Zhang
,
Di Wu
,
+5 authors
Z. Zeng
2014
Corpus ID: 55479941
Objective: To discuss long-term efficacy of preoperative induction chemotherapy (IC) plus surgery ± radiotherapy in patients with…
Expand
2012
2012
Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
K. Luo
,
J. Wen
,
+4 authors
Y. Hu
Annals of Thoracic Surgery
2012
Corpus ID: 10542520
2009
2009
Adjuvant sunitinib following chemoradiotherapy (CRT) and surgery for esophageal cancer: A phase II trial.
A. Horgan
,
G. Darling
,
+7 authors
J. Knox
Journal of Clinical Oncology
2009
Corpus ID: 37237524
e15550 Background: Locally advanced esophageal cancer (LAEC) has a 5-year survival of < 30 %. Most patients (pts) fail after…
Expand
2008
2008
Erlotinib (E) as adjuvant treatment for patients (pts) with resected head and neck squamous cell carcinoma (HNSCC) with evaluation of neoadjuvant biomarker modulation with E with or without sulindac…
J. Grandis
,
S. Lai
,
+7 authors
A. Argiris
2008
Corpus ID: 79447823
6037 Background: Epidermal growth factor receptor (EGFR) and G-protein-coupled receptor (GPCR) ligands, such as prostaglandin E2…
Expand
2008
2008
Efficacy and toxicity of cetuximab (C225) plus mFOLOFX6 in patients (pts) with nonoptimally resectable, colorectal metastases (MCRC) confined to the liver
S. Alberts
,
J. Donohue
,
+5 authors
P. Flynn
2008
Corpus ID: 56778105
2007
2007
[Evaluation of efficacy and clinical impact of FDG-PET on patients with potentially resectable non-small cell lung cancer].
I. Borrego Dorado
,
C. López García
,
R. V. Vázquez Albertino
,
A. Ginel Cañamaque
,
E. Barrot Cortés
Revista Española de Medicina Nuclear
2007
Corpus ID: 10512932
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE